| 5KPM: reference: Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia., Wagner FF, Benajiba L, Campbell AJ, Weiwer M, Sacher JR, Gale JP, Ross L, Puissant A, Alexe G, Conway A, Back M, Pikman Y, Galinsky I, DeAngelo DJ, Stone RM, Kaya T, Shi X, Robers MB, Machleidt T, Wilkinson J, Hermine O, Kung A, Stein AJ, Lakshminarasimhan D, Hemann MT, Scolnick E, Zhang YL, Pan JQ, Stegmaier K, Holson EB, Sci Transl Med. 2018 Mar 7;10(431). pii: 10/431/eaam8460. doi:, 10.1126/scitranslmed.aam8460. PMID: 29515000 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).